Askew David J, Askew Yuko S, Kato Yukari, Turner Russell F, Dewar Ken, Lehoczky Jessica, Silverman Gary A
Department of Pediatrics and the Division of Newborn Medicine, Harvard Medical School, Children's Hospital, 300 Longwood Avenue, Enders 9, Boston, MA 02115, USA.
Genomics. 2004 Jul;84(1):176-84. doi: 10.1016/j.ygeno.2004.01.015.
The human clade B serpins neutralize serine or cysteine proteinases and reside predominantly within the intracellular compartment. Genomic analysis shows that the 13 human clade B serpins map to either 6p25 (n = 3) or 18q21 (n = 10). Similarly, the mouse clade B serpins map to syntenic loci at 13A3.2 and 1D, respectively. The mouse clade B cluster at 13A3.2 shows a marked expansion in the number of serpin genes (n = 15). The purpose of this study was to determine whether a similar expansion occurred at 1D. Using STS-content mapping, comparative genomic DNA sequence analysis, and cDNA cloning, we found that the mouse clade B cluster at 1D showed nearly complete conservation of gene number, order, and orientation relative to those of 18q21. The only exception was the squamous cell carcinoma antigen (SCCA) locus. The human SCCA locus contains two genes, SERPINB3 (SCCA1) and SERPINB4 (SCCA2), whereas the mouse locus contains four serpins and three pseudogenes. Based on phylogenetic analysis and predicted amino acid sequences, amplification of the mouse SCCA locus occurred after rodents and primates diverged and was associated with some diversification of proteinase inhibitory activity relative to that of humans.
人类B族丝氨酸蛋白酶抑制剂可中和丝氨酸或半胱氨酸蛋白酶,主要存在于细胞内区室。基因组分析表明,13种人类B族丝氨酸蛋白酶抑制剂基因定位于6p25(n = 3)或18q21(n = 10)。同样,小鼠B族丝氨酸蛋白酶抑制剂基因分别定位于13A3.2和1D的同线位点。位于13A3.2的小鼠B族丝氨酸蛋白酶抑制剂基因簇显示丝氨酸蛋白酶抑制剂基因数量显著增加(n = 15)。本研究的目的是确定1D位点是否发生了类似的基因扩增。通过序列标签位点(STS)含量作图、比较基因组DNA序列分析和cDNA克隆,我们发现位于1D的小鼠B族丝氨酸蛋白酶抑制剂基因簇与18q21的基因簇相比,在基因数量、顺序和方向上几乎完全保守。唯一的例外是鳞状细胞癌抗原(SCCA)位点。人类SCCA位点包含两个基因,即丝氨酸蛋白酶抑制剂B3(SCCA1)和丝氨酸蛋白酶抑制剂B4(SCCA2),而小鼠位点包含四个丝氨酸蛋白酶抑制剂基因和三个假基因。基于系统发育分析和预测的氨基酸序列,小鼠SCCA位点的扩增发生在啮齿动物和灵长类动物分化之后,并且与相对于人类的蛋白酶抑制活性的一些多样化有关。